EVOGENE LTD's ticker is EVGN and the CUSIP is M4119S104. A total of 35 filers reported holding EVOGENE LTD in Q3 2023. The put-call ratio across all filers is 2.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,795 | -9.1% | 30,388 | +66.1% | 0.00% | – |
| Q2 2023 | $19,578 | -62.6% | 18,297 | -78.0% | 0.00% | – |
| Q1 2023 | $52,307 | -33.9% | 83,027 | -26.6% | 0.00% | – |
| Q4 2022 | $79,190 | -19.2% | 113,128 | -4.4% | 0.00% | – |
| Q3 2022 | $98,000 | +139.0% | 118,303 | +120.7% | 0.00% | – |
| Q2 2022 | $41,000 | -61.3% | 53,600 | -34.5% | 0.00% | – |
| Q1 2022 | $106,000 | -68.1% | 81,844 | -59.6% | 0.00% | – |
| Q4 2021 | $332,000 | -25.9% | 202,395 | +19.1% | 0.00% | – |
| Q3 2021 | $448,000 | -66.1% | 169,963 | -56.0% | 0.00% | – |
| Q2 2021 | $1,320,000 | -38.3% | 386,205 | -9.0% | 0.00% | – |
| Q1 2021 | $2,138,000 | +6796.8% | 424,256 | +2089.7% | 0.00% | – |
| Q3 2019 | $31,000 | +10.7% | 19,375 | +39.9% | 0.00% | – |
| Q4 2018 | $28,000 | – | 13,849 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eidelman Virant Capital | 117,000 | $101,000 | 0.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,322 | $156,000 | 0.05% |
| Senvest Management, LLC | 230,606 | $178,000 | 0.01% |
| Susquehanna International Group Ltd. | 28,718 | $21,000 | 0.01% |
| Vident Investment Advisory, LLC | 87,714 | $68,000 | 0.00% |
| MGO ONE SEVEN LLC | 15,340 | $12,000 | 0.00% |
| Csenge Advisory Group | 31,962 | $24,000 | 0.00% |
| SNS Financial Group, LLC | 10,000 | $8,000 | 0.00% |
| Sigma Planning Corp | 31,810 | $24,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 10,249 | $8,000 | 0.00% |